{"id":6380,"date":"2025-04-10T09:06:27","date_gmt":"2025-04-10T09:06:27","guid":{"rendered":"https:\/\/tst.incliva.es\/grupo-de-investigacion-en-enfermedades-respiratorias\/"},"modified":"2025-04-10T09:06:27","modified_gmt":"2025-04-10T09:06:27","slug":"grupo-de-investigacion-en-enfermedades-respiratorias","status":"publish","type":"page","link":"https:\/\/tst.incliva.es\/en\/que-hacemos\/areas\/metabolismo-y-dano-organico\/grupo-de-investigacion-en-enfermedades-respiratorias\/","title":{"rendered":"Grupo de Investigaci\u00f3n en Enfermedades Respiratorias"},"content":{"rendered":"

\n
\n

Research Group on Respiratory Diseases<\/h3>\n<\/div>\n
<\/div><\/div>\n
Metabolism and Organic Damage Area<\/span><\/h5>\n<\/div>\n
<\/div><\/div>\n
\n
\n Study of respiratory complications in patients with neuromuscular diseases. Utility of mechanical ventilation and other respiratory supports <\/p>\n

Implication of early diagnosis of obstructive airway diseases in the prognosis and follow-up of patients. Emphysema early detection program. Program for early detection of Alpha 1 Antitrypsin Deficiency <\/p>\n

Early follow-up program for COPD with exacerbator phenotype <\/p>\n

Severe Asthma control program <\/p>\n

Control of respiratory disorders during sleep as prevention of cardiovascular risk factors <\/p>\n

Early diagnosis of idiopathic interstitial respiratory diseases (IPF) and secondary diseases (drug toxicity and post-BMT)
\n\n<\/div>\n<\/div>\n<\/div><\/div>